Suchergebnisse - "Tian, Hui"

PubPharm (28)

1

Astragaloside-IV promotes autophagy via the Akt/mTOR pathway to improve cellular lipid deposition

enthalten in: Medicine | 2024

von Liu, G. | Wang, Y. | Zhang, T. | +8

2

EID3 inhibits the osteogenic differentiation of periodontal ligament stem cells and mediates the signal transduction of TAZ-EID3-AKT/MTOR/ERK

enthalten in: Biochimica et biophysica acta. Molecular cell research | 2024

von Jia, L. | Tian, H. | Sun, S. | +2

3

Machine learning developed a PI3K/Akt pathway-related signature for predicting prognosis and drug sensitivity in ovarian cancer

enthalten in: Aging | 2023

von Han, X. | Yang, L. | Tian, H. | +1

4

EIF4A3 Acts on the PI3K-AKT-ERK1/2-P70S6K Pathway through FLOT1 to Influence the Development of Lung Adenocarcinoma

enthalten in: Molecular cancer research : MCR | 2023

von Yu, W. | Liang, J. | Fang, T. | +5

5

UHMK1 promotes lung adenocarcinoma oncogenesis by regulating the PI3K/AKT/mTOR signaling pathway

enthalten in: Thoracic cancer | 2023

von Li, Y. | Wang, S. | Jin, K. | +4

6

Discovery of 4-aminopyrimidine analogs as highly potent dual P70S6K/Akt inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2021

von Xiao, Y. | Huck, B. | Lan, R. | +23

ErratumIn: Bioorg Med Chem Lett. 2022 Jul 1;67:128758. - PMID 35484006

7

Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers

enthalten in: Journal of medicinal chemistry | 2021

von DeSelm, L. | Huck, B. | Lan, R. | +23

8

Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer

enthalten in: Journal of hematology & oncology | 2021

von Tsimberidou, A. | Shaw, J. | Juric, D. | +12

9

Dioscin inhibits SCC15 cell proliferation via the RASSF1A/MST2/YAP axis

enthalten in: Molecular medicine reports | 2021

von Tian, H. | Chen, X. | Zhang, Y. | +4

10

Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells

enthalten in: Oncology reports | 2021

von Wang, Y. | Zhang, Y. | Feng, X. | +4